<DOC>
	<DOC>NCT01158261</DOC>
	<brief_summary>The objective of this non-interventional Post Authorisation Safety Surveillance (PASS) study is to observe the clinical safety performance of EVICEL when used as suture support for haemostasis in vascular surgery.</brief_summary>
	<brief_title>The Evicel Post-Authorization Surveillance Study</brief_title>
	<detailed_description />
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Vascular Diseases</mesh_term>
	<mesh_term>Peripheral Vascular Diseases</mesh_term>
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<mesh_term>Fibrin Tissue Adhesive</mesh_term>
	<criteria>Subjects, 18 years or older, requiring elective, primary or repeat vascular procedures with at least one endtoside anastomosis to the femoral artery or to an upper extremity artery EVICEL Fibrin Sealant is used as an adjunct to obtain haemostasis at a target anastomosis/es Subjects must be willing to and capable of participating in the study, and provide written informed consent Subjects with known intolerance to blood products Subjects unwilling to receive blood products Subjects with any intraoperative findings that may preclude the use of a fibrin sealant to control suture line anastomotic bleeding Subject participating in another study with an investigational (preapproved) drug or device within 30 days of surgery</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>hemostasis</keyword>
</DOC>